Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Do the Outcomes of Clinical Efficacy Trials Matter in Regulatory Decision-Making for Biosimilars? ; volume:37 ; number:6 ; day:13 ; month:10 ; year:2023 ; pages:855-871 ; date:11.2023
BioDrugs ; 37, Heft 6 (13.10.2023), 855-871, 11.2023
- Creator
-
Kirsch-Stefan, Nadine
Guillen, Elena
Ekman, Niklas
Barry, Sean
Knippel, Verena
Killalea, Sheila
Weise, Martina
Wolff-Holz, Elena
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40259-023-00631-4
- URN
-
urn:nbn:de:101:1-2024010808524058902693
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kirsch-Stefan, Nadine
- Guillen, Elena
- Ekman, Niklas
- Barry, Sean
- Knippel, Verena
- Killalea, Sheila
- Weise, Martina
- Wolff-Holz, Elena
- SpringerLink (Online service)
Other Objects (12)
Biosimilars – Biosimilars: ja, aber
Biosimilars
The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects
Biosimilars : Handbuch
Key elements for planning and conducting shared decision-making implementation trials
Decision-making strategies for reperfusion therapies: navigating through stroke trials gaps
Ethical decision-making
Judicial Decision-Making
Divine Decision-Making
The Importance of Patient Reported Outcomes in Oncology Clinical Trials and Clinical Practice to Inform Regulatory and Healthcare Decision-Making
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents
Integrating scientific expertise into regulatory decision-making : national traditions and European innovations
Biosimilars – Biosimilars: ja, aber
Biosimilars
The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects
Biosimilars : Handbuch
Key elements for planning and conducting shared decision-making implementation trials
Decision-making strategies for reperfusion therapies: navigating through stroke trials gaps
Ethical decision-making
Judicial Decision-Making
Divine Decision-Making
The Importance of Patient Reported Outcomes in Oncology Clinical Trials and Clinical Practice to Inform Regulatory and Healthcare Decision-Making
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents
Integrating scientific expertise into regulatory decision-making : national traditions and European innovations
Biosimilars – Biosimilars: ja, aber
Biosimilars
The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects
Biosimilars : Handbuch
Key elements for planning and conducting shared decision-making implementation trials
Decision-making strategies for reperfusion therapies: navigating through stroke trials gaps
Ethical decision-making
Judicial Decision-Making
Divine Decision-Making
The Importance of Patient Reported Outcomes in Oncology Clinical Trials and Clinical Practice to Inform Regulatory and Healthcare Decision-Making
Immunogenicity of Biosimilars for Rheumatic Diseases, Plaque Psoriasis, and Inflammatory Bowel Disease: A Review from Clinical Trials and Regulatory Documents